GENEVA, Oct. 5 -- DAIICHI SANKYO COMPANY, LIMITED filed a patent application (IB2026/053045) for “COMBINATION OF ANTI-MUC1 ANTIBODY-DRUG CONJUGATE WITH IMMUNE CHECKPOINT INHIBITOR”. With publication no. WO/2026/202845, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 47/68
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....